JBIO Stock Analysis: Buy, Sell, or Hold?
JBIO - Jade Biosciences, Inc. Common Stock
$15.34
-0.74 (-4.60%)
▼
5d:
-9.45%
30d:
-38.81%
90d:
+10.2%
HOLD
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When JBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: JBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: JBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: JBIO is currently trading at $15.34, which is considered oversold relative to its 30-day fair value range of $18.06 to $24.88.
Technical Outlook: Technically, JBIO is in a strong uptrend. Immediate support is located at $14.28, while resistance sits at $20.74. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: JBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $49.00 (+219.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, JBIO is in a strong uptrend. Immediate support is located at $14.28, while resistance sits at $20.74. Short-term momentum is weak, with the stock down 4.6% recently.
Market Sentiment: JBIO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $49.00 (+219.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$18.06 -
$24.88
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.6%)
- BULLISH: Trading 219.4% below Wall St target ($49.00)
- CAUTION: 5-day price weakness (-9.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$18.06 -
$24.88
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$14.28
Resistance Level
$20.74
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.87
Wall Street Target
$49.00
(+219.4%)
Share & Embed Analysis
Last updated: June 15, 2026 7:57 AM ET
Data refreshes hourly during market hours. Next update: 8:57 AM
Data refreshes hourly during market hours. Next update: 8:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 58 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 61 BUY |